SNCA and Parkinson disease: Matsumoto and colleagues proposed a novel method in which α-synuclein-carrying extracellular vesicles derived from erythrocytes can traverse the blood–brain barrier, facilitating communication between the brain and the periphery in the development and advancement of Parkinson’s disease [18].